Indefinite Delivery Contract SPE2DU25D9517

The key details of this federal contract IDV award are as follows:

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The $4,999,999 IDC, valid through December 2036, enables DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications.

This IDC is part of DLA's upcoming Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) solicitation, which aims to establish multiple regional prime vendor contracts to provide worldwide pharmaceutical support to the Department of Defense, United States Coast Guard, and other government agencies. The PPV-G GEN V contracts will have a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. Awards will be made on a regional basis, with at least three different contractors selected, to ensure the diversification of the pharmaceutical supply chain and increase the government's resiliency during contingencies or natural disasters.